P666: ACALABRUTINIB ± OBINUTUZUMAB VS OBINUTUZUMAB + CHLORAMBUCIL IN TREATMENT-NAIVE CHRONIC LYMPHOCYTIC LEUKEMIA: 5-YEAR FOLLOW-UP OF ELEVATE-TN

• J. P. Sharman,
• M. Egyed,
• W. Jurczak,
• A. Skarbnik,
• K. Patel,
• I. W. Flinn,
• M. Kamdar,
• T. Munir,
• R. Walewska,
• L. M. Fogliatto,
• Y. Herishanu,
• V. Banerji,
• G. Follows,
• P. Walker,
• K. Karlsson,
• P. Ghia,
• A. Janssens,
• F. Cymbalista,
• E. Ferrant,
• W. G. Wierda,
• V. Munugalavadla,
• T. Yu,
• M. H. Wang,
• J. A. Woyach

Affiliations

J. P. Sharman

1 Willamette Valley Cancer Institute and Research Center, Eugene, OR, United States of America

M. Egyed

2 Somogy County Mór Kaposi General Hospital, Kaposvár, Hungary

W. Jurczak

3 Maria Skłodowska-Curie National Research Institute of Oncology, Krakow, Poland

A. Skarbnik

4 Novant Health Cancer Institute, Charlotte, NC

K. Patel

5 Swedish Cancer Institute, Center for Blood Disorders and Stem Cell Transplantation, Seattle, WA

I. W. Flinn

6 Sarah Cannon Research Institute and Tennessee Oncology, Nashville, Tennessee

M. Kamdar

7 University of Colorado Cancer Center, Aurora, CO, United States of America

T. Munir

8 Haematology, Haematological Malignancy Diagnostic Service (HMDS), St. James’s Institute of Oncology, Leeds

R. Walewska

9 Cancer Care, University Hospitals Dorset, Bournemouth, United Kingdom

L. M. Fogliatto

10 Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil

Y. Herishanu

11 Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

V. Banerji

12 Departments of Internal Medicine, Biochemistry & Medical Genetics, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba and CancerCare Manitoba, Winnipeg, Canada

G. Follows

13 Department of Haematology, Addenbrooke’s Hospital NHS Trust, Cambridge, United Kingdom

P. Walker

14 Peninsula Health and Peninsula Private Hospital, Frankston, Melbourne, Australia

K. Karlsson

15 Skåne University Hospital, Lund, Sweden

P. Ghia

16 Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy

A. Janssens

17 University Hospitals Leuven, Leuven, Belgium

F. Cymbalista

18 Bobigny: Hématologie biologique, Hopital Avicenne, Université Sorbonne Paris Nord, Bobigny

E. Ferrant

19 Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Service d’Hématologie Clinique, Pierre-Bénite, France

W. G. Wierda

20 Department of Leukemia, Division of Cancer Medicine, MD Anderson Cancer Center, Houston, Texas

V. Munugalavadla

21 AstraZeneca, South San Francisco, CA

T. Yu

21 AstraZeneca, South San Francisco, CA

M. H. Wang

21 AstraZeneca, South San Francisco, CA

J. A. Woyach

22 The Ohio State University Comprehensive Cancer Center, Columbus, OH, United States of America